Literature DB >> 7537842

CD44 isoforms in prognosis of breast cancer.

K Friedrichs, G Kügler, F Franke, H J Terpe, J Arlt, P A Regidor, U Günthert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7537842     DOI： 10.1016/s0140-6736(95)92018-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Focal loss of CD44 variant protein expression is related to recurrence in superficial bladder carcinoma.

Authors:  V Toma; D Hauri; U Schmid; D Ackermann; R Maurer; G Alund; H Knönagel; M Rist; T C Gasser; G Sauter; J Roth
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Expression analysis of CD44 isoforms S and V3, in patients with esophageal squamous cell carcinoma.

Authors:  Atena Mansouri; Ali Mohammad Foroughmand; Mohammad Reza Abbaszadegan; Bahram Memar; Reihaneh Alsadat Mahmoudian; Mehran Gholamin
Journal:  Iran J Basic Med Sci       Date:  2015-04       Impact factor: 2.699

3.  Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process.

Authors:  Alireza Khodadadi-Jamayran; Betul Akgol-Oksuz; Yelena Afanasyeva; Adriana Heguy; Marae Thompson; Karina Ray; Ariadna Giro-Perafita; Irma Sánchez; Xifeng Wu; Debu Tripathy; Anne Zeleniuch-Jacquotte; Aristotelis Tsirigos; Francisco J Esteva
Journal:  Oncotarget       Date:  2018-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.